The ESMO Targeted Anticancer Therapies Congress 2026 will be held from 16 to 18 March in Paris, France, bringing together experts dedicated to early drug development in oncology.
This unique forum connects researchers, industry leaders, regulators, investors, and patient advocates, all working to accelerate the discovery and delivery of innovative targeted therapies for cancer treatment.
With a focus on sharing new data, fostering collaboration, and addressing key challenges in early clinical development, the congress offers a valuable platform for advancing cancer care. Participants can expect insightful discussions, networking opportunities, and exposure to the latest breakthroughs in anticancer therapies. Elena Garralda, Carlos Gomez-Roca, and Cristian Massacesi serve as the co-chairs.
